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Abstract
Background: Pericardial effusion (PE) is a common finding in patients who had chronic cardiac failure, who had
undergone cardiac surgery, or who had certain other benign and malignant diseases. PE ranges in severity from
mild, asymptomatic effusions to cardiac tamponade. Although a thoracoscopic pericardial window (TPW) is a
minimally invasive surgical option for patients with PE, there are few published data regarding the outcomes of
TPW for PE. We investigated the contribution of the TPW to the treatment of PEs that are recurrent or difficult to
drain percutaneously.
Methods: We conducted a retrospective chart review of the indications for TPW that included data on
preoperative, intraoperative, and postoperative variables; morbidity; recurrence; and survival. Fourteen consecutive
patients with PE that was recurrent or difficult to drain percutaneously and who underwent treatment with a TPW
were enrolled in this study. Trocars for passage of the thoracoscope and surgical instruments were introduced
through two or three incisions. Mini-thoracotomy was also performed in patients with hemopericardium and
loculated fibrinous effusions. All patients were evaluated by face-to-face interviews, transthoracic echocardiography
(TTE), and chest radiography 3–6 months after the TPW was obtained.
Results: The mean age of the patients was 70 years (range 28–83 years). The operative time was 72.1 ± 29.5 min.
Six patients had undergone open heart surgery during the month prior to their presentation with PE. No
intraoperative or postoperative complications occurred, although PE had recurred in one patient. Two patients died
of malignant disease several months after the TPW. The cardiothoracic ratio (determined on chest radiographs) and
the ejection fraction ratio (determined using TTE) had improved at the 3- and 6-month follow-up evaluations (p < 0.
0001 and p = 0.012, respectively). Some patients could discontinue diuretics after the procedure, as assessed by the
cardiologist based on symptom alleviation, chest radiography, and TTE findings.
Conclusions: For patients with PEs that are recurrent or difficult to drain percutaneously, TPW is an effective, safe
surgical approach in terms of cardiac function and radiological findings.
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Background
Pericardial effusion (PE) is a common finding in patients
who had chronic cardiac failure, who had undergone
cardiac surgery, or who had certain other benign and
malignant diseases. Its severity ranges from mild, asymp-
tomatic effusion to cardiac tamponade [1–3]. Repeated
percutaneous pericardiocentesis or temporary pericardial
drainage is frequently required. Performance of peri-
cardiocentesis from the parasternal or xiphoid process
region is sometimes difficult because of factors such as
hepatomegaly and the main location of the PE. If peri-
cardiocentesis is not feasible or fails, creation of a so-
called pericardial window should be considered either by
conventional heart surgery or video-assisted thoraco-
scopy [3]. A thoracoscopic pericardial window (TPW),
another option for managing PE, requires a surgeon with
experience in thoracoscopy. A true window can be cre-
ated by partial pericardiectomy, creating a passage that
presumably allows longer-term drainage into an adjacent
space, usually the pleural space [2]. Additionally, the
TPW usually enables treatment while establishing a
diagnosis by pericardiectomy [4], and it is less invasive
than conventional thoracotomy. Despite these advan-
tages, however, there are few published data regarding
the outcome of TPW for PEs that are recurrent or diffi-
cult to drain. The purpose of this study was to evaluate
retrospectively the efficacy and safety of TPW in patients
with PE that were recurrent or difficult to drain
percutaneously.
Methods
Data were collected from inpatient records of 14 pa-
tients who had undergone TPW procedures for PE that
had been diagnosed by transthoracic echocardiography
(TTE) from 2010 to 2014 at the Department of Thoracic
Surgery of Kobe City Medical Center General Hospital.
The institutional review board approved use of these
data for research (No. 14043; August 11, 2015). Specific
individual consent for the study was waived. All patients
had PE that was recurrent or difficult to drain. The pro-
priety of percutaneous drainage before TPW and the ne-
cessity of TPW were evaluated by a cardiologist based
on clinical symptoms and computed tomography (CT)
and TTE findings. Patients with PE due to blunt chest
trauma were excluded from this study.
Preoperatively, all patients underwent a blood count,
clotting tests, routine biochemical tests, chest radiography,
and CT. They then underwent TPW under general
anesthesia in a lateral position with single-lung ventilation
using a double-lumen endotracheal tube. Trocars for pas-
sage of the thoracoscope and surgical instruments were
introduced through two or three incisions. A 3- to 4-cm
mini-thoracotomy was also performed in patients with
hemopericardium and loculated fibrinous effusion. A 5-
or 10-mm thoracoscope (HOPKINS II Telescope; Karl
Storz, Tuttlingen, Germany) was used for the procedure.
A portion of pericardium (2 cm diameter) was
resected anterior to the phrenic nerve by a scalpel or
scissors (Fig. 1). Any existing PE was removed at the
same time. A chest drain was placed in the pleural cavity
in all cases and was removed once the daily drainage
had decreased to <200 mL. All patients were evaluated
in terms of demographic characteristics as well as the
nature and amount of effusion, operation time, and
treatment results using face-to-face interviews, TTE, and
chest radiography 3–6 months after the surgery.
Changes in clinical symptoms before and after TPW
were obtained during the interviews. Recurrence was
defined as an effusion visible on postoperative TTE and
requiring further therapy.
Student’s paired t-test was performed using EZR soft-
ware (Saitama Medical Center, Jichi Medical University,
Saitama, Japan) to assess the statistical significance of
differences. A value of p < 0.05 was considered to indi-
cate statistical significance. EZR is a graphic user inter-
face for R software (The R Foundation for Statistical
Computing, Vienna, Austria).
Results
The patients’ clinical data are shown in Table 1. There
were eight male and six female patients with a median
age of 70 years (range 28–83 years). All of the patients
had symptoms, such as fatigue, dyspnea on effort, and/
or edema. Six patients had undergone open heart sur-
gery during the month prior to their presentation with
PE. The propriety of performing pericardiocentesis be-
fore the TPW and the need to create a TPW were evalu-
ated by a cardiologist based on clinical symptoms and
CT and TTE findings.
Eight patients had undergone pericardiocentesis before
TPW. The other six had not because of various anatom-
ical difficulties, which were assessed by the cardiologist.
The operative side was the right in six patients and the
left in eight. The TPW operation time was 72.1 ±
29.5 min (mean ± SD).
Fig. 1 a Process of creating a pericardial window with an electric
scalpel. b Completion of pericardial window, which is 2–4 cm
in diameter
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There were no intraoperative or postoperative compli-
cations associated with the procedure. The PE recurred
following TPW usage in one patient (case 10), who
underwent pericardiectomy for chronic constrictive peri-
carditis 1 month after use of the TPW. Patients 7 and 11
died of malignant diseases 3 and 5 months, respectively,
after TPW usage.
The average cardiothoracic ratio on chest radiography
was decreased at 0.098 and the average ejection fraction
ratio on TTE was improved by 6.9 % at the 3- to 6-
month follow-up evaluation. Both of these changes were
statistically significant (p < 0.001 and p = 0.012, respect-
ively) (Fig. 2). Moreover, some patients were able to dis-
continue diuretics after the procedure, a decision made
by the cardiologist based on alleviation of symptoms,
chest radiography, and TTE findings.
Discussion
Various approaches to the diagnostic and therapeutic as-
sessments of pericardial diseases have been described,
including pericardiocentesis, percutaneous catheter
drainage, balloon pericardiotomy, subxiphoid pericardial
drainage, pericardioperitoneal shunt, subxiphoid pericar-
dial fenestration, and pericardial window creation via an-
terior thoracotomy or thoracoscopy [5].
Pericardiocentesis is noninvasive and may result in
prompt relief for patients with pericardial tamponade. A
high complication rate has been reported, however,
Table 1 Preoperative and postoperative characteristics of patients (n = 14)
Patient Age (years), sex Etiology Symptoms Side of surgery Operation duration (min) PE volume (mL) Type of PE
1a,b 62 M After cardiac surgery Fatigue Left 141 950 Serous
2 65 F After cardiac surgery Fever Left 102 60 Serous
3b 77 M After aortic surgery DOE, fatigue Left 68 230 Bloody
4a 76 F Heart failure Fatigue, edema Right 53 350 Serous
5a,b 80 F Heart failure Dyspnea, edema Right 31 350 Serous
6ab 83 M Idiopathic DOE, edema Left 84 1250 Bloody
7a 76 F Heart failure Edema, oliguria Right 37 630 Serous
8 65 M Malignant disease DOE, tachycardia Right 52 600 Bloody
9a 78 M After cardiac surgery Fatigue, edema Left 60 N/A Hematoma
10b 61 M After cardiac surgery Dyspnea, edema Left 71 200 Bloody
11b 28 F Malignant disease Dyspnea, edema Right 107 230 Bloody
12 65 F After cardiac surgery DOE, edema Left 89 N/A Hematoma
13a,b 70 M Chronic pericarditis Edema Right 75 420 Serous
14a,b 74 M After cardiac surgery Dyspnea, edema Left 40 600 Serous
Mean ± SD 72.1 ± 29.5
M male, F female, DOE dyspnea on effort, N/A not available, PE pericardial effusion
aPericardiocentesis was performed before creation of the thoracoscopic pericardial window (TPW)
bPleural effusion was performed at the same time as creation of the TPW
Fig. 2 Changes in the cardiothoracic ratio (a) and ejection fraction (b) before and after creating a thoracoscopic pericardial window (TPW). The
data show significant changes after the TPW was created as evaluated by the paired t-test (p < 0.001 and p = 0.012, respectively)
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especially if pericardiocentesis is performed for small,
loculated effusions and particularly without echo-
cardiographic visualization [6]. The most serious com-
plications of pericardiocentesis are laceration and
perforation of the myocardium and coronary vessels.
Patients could also experience air embolism, pneumo-
thorax, arrhythmias (usually vasovagal bradycardia),
and puncture of the peritoneal cavity or abdominal
viscera [3]. Prolonged catheter drainage is an effective
means of preventing fluid reaccumulation, although
the mechanism by which it occurs is probably related
more to obliteration of the pericardial space after
catheter-provoked inflammation than to the fluid
drainage itself. This approach is reportedly successful
in >70 % of cases, although the duration of effusion
control is often not reported [7, 8].
Our study indicates that the TPW for patients with
PEs that are recurrent or difficult to drain percutan-
eously is an effective, safe procedure. Unlike pericardio-
centesis, TPW drains PEs into the thoracic cavity
through a pericardial window [1, 2, 4]. The effusion is
then absorbed through the pleura. Because general
anesthesia with single-lung ventilation is necessary to
create the TPW, it is not the first choice for managing
PE. However, it should be considered as an option in pa-
tients who have recurrent PE caused by some inflamma-
tory diseases or chronic heart failure, those who have
undergone cardiac surgery, or patients in whom the risk
of complications associated with pericardiocentesis is
high. TPW allows us easy visualization of the pericar-
dium. The frequency of laceration and peroration of the
myocardial structure is expected to be low, especially in
patients with PEs that are difficult to drain percutan-
eously. Celik et al. reported that TPW is also safe and ef-
fective for patients with cancer [9].
In our study, two patients for whom TPW was effect-
ive died of malignant disease progression within
6 months after TPW usage (Table 1). Hence, the prog-
nosis of any co-morbidities should be taken into account
when considering this procedure. Given the poor prog-
nosis of most patients presenting with malignant PE, the
primary goals of treatment are to alleviate the symptoms
and improve the patient’s quality of life [3].
An additional benefit of the TPW is that the pathology
examination of the resected pericardium sometimes re-
veals the cause of the PE. Robles et al. reported that
thoracoscopic management of PEs simply and effectively
creates a large pericardial window that drains the effu-
sion and determines its etiology [10]. After TPW cre-
ation in some of our patients, the pathological findings
of the resected pericardium helped us establish the treat-
ment principles.
Pleural effusion can also be removed during the proced-
ure when needed. Eight patients in our study underwent
drainage of pleural effusion at the same time as when the
TPW was performed (Table 1). The combined effect of
TPW and drainage of pleural effusion might result in a fa-
vorable outcome and lower incidence of fluid reaccumula-
tion as a result of improved cardiac function. After TPW
creation, only one patient (case 10) experienced recur-
rence of PE that required an additional procedure or
drainage. Although the other patients had a small amount
of PE, further therapy was not required. Based on these
findings, we believe that pericardial adhesion tends to pro-
gress after the TPW, leading to a lower incidence of
recurrence.
Subxiphoidal window is an alternative to the TPW, but
it can drain PE temporally only while the drainage tube
is connected to a closed bag. Several studies of the sub-
xiphoidal window reported complication rates of < 4 %
[2, 11, 12], although higher rates have been reported as
well [13]. Although six patients in our study had under-
gone prior open heart surgery, no complications associ-
ated with the TPW were observed.
Previous reports have described a low incidence of
pericardial tamponade recurrence and the high safety
of TPW [2]. Few reports have reported changes in
the cardiothoracic ratio and ejection fraction. Based
on the fact that these clinical data improved after the
TPW was in place in our study, the central venous
pressure (CVP) is expected to be a good indicator for
assessing the efficacy of the surgery. In our study,
however, there were too few patients who required
catheterization to justify measuring the CVP pre-
operatively. Our data suggest that the TPW might be
considered a more proactive procedure depending on
the patient’s clinical situation, even when the patient
has undergone cardiac surgery. Additionally, the risk
of effusion recurrence is lower than that associated
with other procedures.
Several recent studies have shown that single-incision
surgery with thoracoscopy is feasible and less invasive
than other methods for treating thoracic diseases [14,
15]. Similar studies should be performed to clarify the
efficacy and safety of single-incision surgery with thora-
coscopy for treating PE.
This study has several limitations. First, because it
was a retrospective study, there was potential patient
selection bias owing to the wide variety of etiological
agents. Evidence that the TPW is the only, or best, way
to avoid repeated pericardiocentesis is inconclusive be-
cause the effects of diuretics and other medications
cannot be eliminated. Second, only 14 patients were
evaluated, and the incidence of long-term recurrence
and cardiac function are unknown. Furthermore, one
patient required reoperation. The optimal diameter of
the pericardial fenestration and the incidence of adhe-
sions were also not established.
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Conclusions
Although the TPW requires general anesthesia with
single-lung ventilation, it is effective and safe in patients
with PEs that are recurrent or difficult to drain percu-
taneously. Further clinical studies, especially randomized
trials, are needed to evaluate the role of the TPW in
such cases.
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